Probiotics Irritable Bowel Syndrome Meta Analysis Evidence Table

Structured evidence table for Probiotics Irritable Bowel Syndrome Meta Analysis, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Probiotics Irritable Bowel Syndrome Meta AnalysisThis review summarizes the current concepts of probiotics and evaluates evidence supporting their use in patients with lower GI disorders, with a focus on potential sex-related differences.2Kim Yong Sung (2026)Clinical Guidance and Practical Recommendations for Probiotic Use in Patients With Irritable Bowel Syndrome, Functional Constipation, and Clostridioides difficile Infection Considering Sex-based Differences
Probiotics Irritable Bowel Syndrome Meta AnalysisSaccharomyces, Lactobacillus Bifidobacterium Clostridium difficile 7 This review was conducted to summarize and interpret the current evidence on probiotics on IBS, FC, and CDI in terms of sex differences.2Kim Yong Sung (2026)Clinical Guidance and Practical Recommendations for Probiotic Use in Patients With Irritable Bowel Syndrome, Functional Constipation, and Clostridioides difficile Infection Considering Sex-based Differences
Probiotics Irritable Bowel Syndrome Meta AnalysisOverall, probiotics significantly increased spontaneous bowel movement (SBM) per week by 0.67 (95% CI, 0.22-1.12) at 4 weeks after ingestion ().2Kim Yong Sung (2026)Clinical Guidance and Practical Recommendations for Probiotic Use in Patients With Irritable Bowel Syndrome, Functional Constipation, and Clostridioides difficile Infection Considering Sex-based Differences
Probiotics Irritable Bowel Syndrome Meta AnalysisClostridioides difficile 1 3 - 4 5 4 6 - For over a century, probiotics have been widely consumed as fermented beverages and supplements to promote gut health.2Kim Yong Sung (2026)Clinical Guidance and Practical Recommendations for Probiotic Use in Patients With Irritable Bowel Syndrome, Functional Constipation, and Clostridioides difficile Infection Considering Sex-based Differences
topicProbiotics Irritable Bowel Syndrome Meta Analysis
claimThis review summarizes the current concepts of probiotics and evaluates evidence supporting their use in patients with lower GI disorders, with a focus on potential sex-related differences.
evidence level2
citationKim Yong Sung (2026)
sourceClinical Guidance and Practical Recommendations for Probiotic Use in Patients With Irritable Bowel Syndrome, Functional Constipation, and Clostridioides difficile Infection Considering Sex-based Differences
topicProbiotics Irritable Bowel Syndrome Meta Analysis
claimSaccharomyces, Lactobacillus Bifidobacterium Clostridium difficile 7 This review was conducted to summarize and interpret the current evidence on probiotics on IBS, FC, and CDI in terms of sex differences.
evidence level2
citationKim Yong Sung (2026)
sourceClinical Guidance and Practical Recommendations for Probiotic Use in Patients With Irritable Bowel Syndrome, Functional Constipation, and Clostridioides difficile Infection Considering Sex-based Differences
topicProbiotics Irritable Bowel Syndrome Meta Analysis
claimOverall, probiotics significantly increased spontaneous bowel movement (SBM) per week by 0.67 (95% CI, 0.22-1.12) at 4 weeks after ingestion ().
evidence level2
citationKim Yong Sung (2026)
sourceClinical Guidance and Practical Recommendations for Probiotic Use in Patients With Irritable Bowel Syndrome, Functional Constipation, and Clostridioides difficile Infection Considering Sex-based Differences
topicProbiotics Irritable Bowel Syndrome Meta Analysis
claimClostridioides difficile 1 3 - 4 5 4 6 - For over a century, probiotics have been widely consumed as fermented beverages and supplements to promote gut health.
evidence level2
citationKim Yong Sung (2026)
sourceClinical Guidance and Practical Recommendations for Probiotic Use in Patients With Irritable Bowel Syndrome, Functional Constipation, and Clostridioides difficile Infection Considering Sex-based Differences

Source documents

  1. Clinical Guidance and Practical Recommendations for Probiotic Use in Patients With Irritable Bowel Syndrome, Functional Constipation, and Clostridioides difficile Infection Considering Sex-based Differences
  2. Editorial: Reviews in gastroenterology 2025